HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE
Apolipoprotein AI - Wikipedia
IVD Antibody Development Services for Apolipoprotein A1 Marker - Creative Biolabs
Apolipoproteins and cancer - Ren - 2019 - Cancer Medicine - Wiley Online Library
Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease | PLOS ONE
A) apoA-I genotyping was confirmed using genomic DNA extracted from... | Download Scientific Diagram
An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
Biomedicines | Free Full-Text | Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
Subfractional distribution of Apo B-containing lipoproteins: a new marker for detection of individual cardiovascular risk
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL - ScienceDirect
Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins | ACS Omega
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-s
The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux - Journal of Biological Chemistry
apoA-V Antibody (A-12) | SCBT - Santa Cruz Biotechnology
Apolipo proteins
![Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation](https://cdn11.bigcommerce.com/s-e7c5fvpp1c/images/stencil/500x659/products/264034/260807/monoclonal__71134.1675353318.png?c=2 "Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation")
Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -
SDS-PAGE (left) and Western blot (right) patterns of samples. (A)... | Download Scientific Diagram
